Bharat Biotech gets DCGI nod for Phase 2,3 Covaxin trials on 2 to 18 years Ruchika Sharma14 May 2021 3:02 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the...
Cannot provide additional Covaxin doses: Bharat Biotech informs Delhi Govt Ruchika Sharma13 May 2021 2:47 PM ISTNew Delhi: Deputy Chief Minister Manish Sisodia on Wednesday said Covaxin maker Bharat Biotech has refused to provide "additional" vaccine doses to...
Bharat Biotech gets CDSCO panel nod to conduct Covaxin trials on 2-18 years old Ruchika Sharma12 May 2021 12:37 PM ISTNew Delhi: Bharat Biotech's Covid-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged...
Bharat Biotech joint MD says tech transfers, supply of materials must to scale up COVID vaccine production Ruchika Sharma10 May 2021 3:34 PM ISTNew Delhi: Partnerships, technology transfers and supply of various critical equipment and materials which go into the production of COVID-19 vaccines...
After Serum Institute, Bharat Biotech reduces Covaxin price to Rs 400 for states Ruchika Sharma30 April 2021 1:00 PM ISTNew Delhi: Bharat Biotech on Thursday announced a cut in the price of its COVID-19 vaccine ''Covaxin'' it plans to sell to the states to Rs 400...
Plea asks to direct Serum Institute, Bharat Biotech sell vaccines at uniform rate of Rs 150 Ruchika Sharma29 April 2021 10:00 AM ISTMumbai: A public interest litigation (PIL) has been filed in the Bombay High Court challenging the different rates for COVID-19 vaccines for the...
Central Govt asks Bharat Biotech, Serum Institute to lower COVID vaccine prices Ruchika Sharma27 April 2021 3:28 PM ISTNew Delhi: The central government on Monday asked the Serum Institute and Bharat Biotech to lower prices of their Covid-19 vaccines amid criticism...
COVID Vaccination in India- Developments and Controversies Medical Dialogues Team26 April 2021 8:08 PM ISTNew Delhi: Engulfed by a calamitous coronavirus wave, the Government rolled out anti-COVID vaccines for the immunization programme against the deadly...
Bharat Biotech seeks DCGI nod for extension of Covaxin shelf life from 6 to 24 months Ruchika Sharma26 April 2021 12:48 PM ISTNew Delhi: Bharat Biotech has written to India's drug regulator seeking extension of the shelf-life of its indigenously developed Covid-19 vaccine...
Bharat Biotech Covaxin shows 78 percent overall interim efficacy, 100 percent efficacy against severe Covid Ruchika Sharma22 April 2021 11:30 AM ISTHyderabad: Drugmaker, Bharat Biotech, has recently announced phase 3 interim analysis results of COVAXIN. The second interim analysis is based...
Bharat Biotech to expand Covaxin production capacity to 700 million doses annually Ruchika Sharma21 April 2021 10:30 AM ISTHyderabad: Bharat Biotech recently announced that it has scaled up its COVID-19 vaccine Covaxin manufacturing capacity to 700 million doses per...
Serum Institute, Bharat Biotech to get Rs 45.67 billion to boost Covid-19 vaccine production capacity Ruchika Sharma20 April 2021 10:30 AM ISTNew Delhi: India's government has approved a 45.67-billion-rupee ($610 million) grant for COVID-19 vaccine makers Serum Institute of India (SII) and...
